10 Overstated
Peripheral neuropathy can usually be greatly improved with benfotiamine and alpha-lipoic acid.
"could it be a peripheral neuropathy, which usually can be improved greatly with taking benfotiamine and alpha-lipoic acid." (said at 0:05:56)
While alpha-lipoic acid (ALA) and benfotiamine have been studied as pathogenetically oriented treatments primarily in diabetic peripheral neuropathy, asserting that peripheral neuropathy "usually can be improved greatly" with these supplements overstates the evidence. Systematic reviews and randomized controlled trials show that ALA provides modest short-term symptomatic relief (such as reduction in pain and paresthesias), but long-term data (such as the 4-year NATHAN 1 trial) show limited, borderline functional benefits and no clear disease-modifying or nerve-regenerative effects. For benfotiamine, evidence is limited to small, short-duration trials, and systematic reviews (including Cochrane) have found insufficient evidence to establish strong efficacy across peripheral neuropathies.
- contradicts: Vitamin B for treating peripheral neuropathy. (The Cochrane database of systematic reviews 2008) · cited 117x in the literature
"There are only limited data in randomised trials testing the efficacy of vitamin B for treating peripheral neuropathy and the evidence is insufficient to determine whether vitamin B is beneficial or harmful." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: Alpha-Lipoic Acid and Benfotiamine in Diabetic Peripheral Neuropathy: A Critical Review of… (Nutrients 2026) · cited 1x in the literature
"ALA consistently improves short-term symptoms across multiple randomized trials. The long-term NATHAN 1 trial reported a marginal, borderline significant effect on the primary composite endpoint (NIS-LL, p = 0.05) without significant improvements in nerve conduction studies; therefore, evidence for functional stabilization is very limited and inconclusive... Benfotiamine has a strong biochemical rationale... but clinical evidence remains limited to short-duration, symptom-based studies, with no large-scale, long-term trials published." (abstract, results, passage verified)
pubmedfull study (doi)
Taking 50,000 IUs of vitamin D3 with magnesium and K2 for 3 days before any surgical procedure greatly improves outcomes.
"before the surgery, you definitely need to do, for like 3 days before the surgery, I would take at least 50,000 IUs of vitamin D3 with the magnesium, K2, because that would improve your outcomes greatly. Any type of surgical procedure, vitamin D, hands down, no matter what surgery, people going into it with more vitamin D will have way better outcomes." (said at 0:07:28)
While baseline vitamin D deficiency is associated with poorer postoperative recovery and higher complication rates in certain surgical settings (such as orthopedic procedures or post-CABG atrial fibrillation), evidence does not support universal high-dose supplementation (50,000 IU daily for 3 days alongside magnesium and vitamin K2) across all surgical procedures. Systematic reviews of micronutrient supplementation in perioperative care conclude that routine high-dose supplementation is not justified, recommending instead targeted screening and correction of deficiencies in high-risk patients. Furthermore, randomized controlled trials evaluating high-dose preoperative vitamin D (such as 50,000 IU) have failed to demonstrate broad improvements in functional recovery or complication rates compared to placebo.
- contradicts: Vitamin D 3 Supplementation Prior to Total Knee Arthroplasty: A Randomized Controlled Tria… (The Journal of arthroplasty 2023) · cited 18x in the literature
"Supplementation with 50,000 international units vitamin D 3 on the day of surgery failed to demonstrate statistical significant differences in functional KSS, TUGT times, or complications in the early postoperative period compared to placebo." (abstract, conclusions, passage verified)
pubmedfull study (doi) - context: Vitamin D Deficiency Leads to Poorer Health Outcomes and Greater Length of Stay After Tota… (JBJS reviews 2024) · cited 18x in the literature
"Vitamin D deficiency results in poorer outcomes of primary TKA, with improved outcomes after supplementation. Further studies should examine the role of preoperative vitamin D screening and/or perioperative supplementation in primary TKA and standardize outcome measures to assess their effect." (abstract, conclusions, passage verified)
pubmedfull study (doi) - contradicts: Role of Micronutrients in Perioperative Care: A Systematic Review. (Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 2026)
"Routine high-dose supplementation is not justified. Targeted preoperative screening and correction of iron, vitamin D, zinc, and selenium deficiencies may improve recovery in high-risk surgical patients." (abstract, conclusions, passage verified)
pubmedfull study (doi)
High therapeutic doses of vitamin D3 administered under the Coimbra protocol can put autoimmune diseases into remission without the side effects of steroids.
"You want to find a doctor who knows the Coimbra protocol from Brazil, this Dr. Coimbra, uh, using high vitamin D. There's um It's fantastic for autoimmune because it can actually be something that won't have the side effects that the steroids have, and um if you get a doctor to help you go through that and monitor the the dose, the therapeutic doses of vitamin D3, potentially you can put that thing in remission." (said at 0:29:05)
The assertion that high-dose vitamin D3 under the Coimbra protocol puts autoimmune diseases into remission is overstated. Published literature on the Coimbra protocol consists primarily of mechanistic hypothesis papers, uncontrolled clinical series, and observational safety cohorts evaluating high doses (often exceeding 30,000 IU/day) paired with strict calcium-restricted diets. These publications describe clinical observations and safety parameters under medical monitoring, but they lack randomized, controlled comparative evidence demonstrating clinical remission or equivalence to corticosteroids. Moreover, meta-analyses of randomized controlled trials examining high-dose vitamin D3 in autoimmune conditions such as multiple sclerosis have shown no significant effect on clinical disability or relapse rates.
- partial: Vitamin D Resistance as a Possible Cause of Autoimmune Diseases: A Hypothesis Confirmed by… (Frontiers in immunology 2021) · cited 64x in the literature
"We particularly focus on its clinical confirmation from our experience of treating multiple sclerosis patients with the so-called Coimbra protocol, in which daily doses up to 1000 I.U. vitamin D 3 per kg body weight can be administered safely. Parathyroid hormone levels in serum thereby provide the key information for finding the right dose. We argue that acquired vitamin D resistance provides a plausible pathomechanism for the development of autoimmune diseases, which could be treated using high-dose vitamin D 3 therapy." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Safety Data in Patients with Autoimmune Diseases during Treatment with High Doses of Vitam… (Nutrients 2022) · cited 26x in the literature
"Mean vitamin D3 dose was 35,291 ± 21,791 IU per day... Our data show the reliable safety of the CP in autoimmune patients under appropriate supervision by experienced physicians." (abstract, results)
pubmedfull study (doi) - contradicts: Vitamin D 3 as an add-on treatment for multiple sclerosis: A systematic review and meta-an… (Multiple sclerosis and related disorders 2024) · cited 25x in the literature
"We included 9 studies with 867 participants. No significant reduction of EDSS (MD = 0.02, CI 95 % [-0.37; 0.41], p = 0.91), ARR (MD -0.03, CI 95 % [-0.08; 0.02], p = 0.26), or new T2 lesions (MD -0.59, CI 95 % [-1.24;0.07], p = 0.08) was observed at 6-24 months... The findings of this meta-analysis strengthen current evidence that vitamin D 3 supplementation has no significant impact on clinical outcomes in patients with MS." (abstract, results, passage verified)
pubmedfull study (doi)
Using high doses of vitamin D3 can significantly help shrink uterine fibroids.
"And using higher doses of vitamin D3, you can help uh greatly help shrink fibroids." (said at 0:30:27)
While clinical studies and meta-analyses show that vitamin D3 supplementation (typically 50,000 IU weekly for 8–12 weeks) is associated with a modest reduction or stabilization in uterine fibroid size in women with vitamin D deficiency/insufficiency, claiming it can "greatly" shrink fibroids overstates the effect. A 2024 meta-analysis of randomized controlled trials reported a modest standardized mean difference (SMD: -0.48, 95% CI: -0.66 to -0.31) in fibroid size compared to controls. Another 2024 meta-analysis found a mean percentage reduction difference of only -5.7% (95% CI: -10.63% to -0.76%) between supplemented patients and controls. Individual trials often show stabilization or small, statistically non-significant volume decreases rather than substantial shrinkage.
- context: Effect of Oral Consumption of Vitamin D on Uterine Fibroids: A Systematic Review and Meta-… (Nutrition and cancer 2024) · cited 6x in the literature
"Pooling results from five trials, which compared size of UFs between experimental and placebo groups, revealed that vitamin D supplementation could significantly decrease the size of UFs (standardized mean difference [SMD]: -0.48, 95% confidence interval [CI]: -0.66, -0.31) and cause improvement in serum level of vitamin D compared to placebo group (SMD: 3.1, 95% CI: 0.66, 5.55)." (abstract, results, passage verified)
pubmedfull study (doi) - context: The Association of Vitamin D with Uterine Fibroids in Premenopausal Patients: A Systematic… (Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2024) · cited 9x in the literature
"Patients receiving oral vitamin D supplementation had a significantly different change in fibroid size (standardized mean difference -5.7%; CI -10.63 to -0.76, P = 0.02, I 2 = 99%), as measured by the percentage change in diameter or volume, compared to controls, over the span of 2-6 months." (abstract, results, passage verified)
pubmedfull study (doi)
A Japanese study demonstrated that high-dose vitamin K2 (40 to 45 milligrams) can reverse osteoporosis.
"the K2 you want it like in 40 to 45 milligrams, not micrograms, because there's been a study out of Japan that showed that when you take higher amounts of K2, you can actually uh reverse osteoporosis." (said at 0:36:57)
Japanese clinical trials evaluated high-dose vitamin K2 (menatetrenone at 45 mg/day) for postmenopausal osteoporosis. However, these trials found that 45 mg of vitamin K2 helped maintain bone mineral density (BMD) and reduce subsequent fracture risk compared to untreated controls, rather than 'reversing' osteoporosis. For example, a 24-month randomized study in Japan by Shiraki et al. (2000) showed that 45 mg/day of vitamin K2 prevented bone loss (-0.5% change in lumbar BMD vs. -3.3% in controls) and reduced clinical fractures, but noted that the treatment group did not show substantial gains in bone mineral density. Describing this effect as reversing osteoporosis overstates the therapeutic benefit.
- context: Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral… (Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000) · cited 411x in the literature
"The percentages of change from the initial value of LBMD at 6, 12, and 24 months after the initiation of the study were -1.8 +/- 0.6%, -2.4 +/- 0.7%, and -3.3 +/- 0.8% for the control group, and 1.4 +/- 0.7%, -0.1 +/- 0.6%, and -0.5 +/- 1.0% for the vitamin K2-treated group, respectively... These findings suggest that vitamin K2 treatment effectively prevents the occurrence of new fractures, although the vitamin K2-treated group failed to increase in LBMD." (abstract, results, passage verified)
pubmedfull study (doi) - context: Vitamin K to prevent fractures in older women: systematic review and economic evaluation. (Health technology assessment (Winchester, England) 2009) · cited 91x in the literature
"Four open-label trials used 45 mg of menatetrenone (vitamin K2) in Japanese women with osteoporosis; the comparators were no treatment, etidronate or calcium... The smaller menatetrenone trials found that menatetrenone was associated with a reduced risk of morphometric vertebral fractures relative to no treatment or calcium; however, the larger Osteoporosis Fracture (OF) study found no evidence of a reduction in vertebral fracture risk." (abstract, results)
pubmedfull study (doi)
Vitamin K2 prevents calcium from depositing in soft tissues.
"And also K2 keeps the um calcium out of the soft tissues." (said at 0:37:23)
Biochemically, vitamin K (including vitamin K2) acts as an essential cofactor for the gamma-carboxylation and activation of Matrix Gla Protein (MGP), a key physiological inhibitor of soft tissue and vascular calcification. However, claiming that vitamin K2 supplementation definitively prevents calcium deposition in soft tissues overstates the clinical trial evidence. Systematic reviews and meta-analyses of randomized controlled trials indicate that while vitamin K supplementation reliably increases MGP carboxylation, it has not consistently prevented the progression of vascular or arterial calcification in clinical outcome studies.
- supports: Vitamin k dependent proteins and the role of vitamin k2 in the modulation of vascular calc… (Oman medical journal 2014) · cited 95x in the literature
"One such VKDP is Matrix Gla Protein (MGP), which when activated inhibits osteogenic factors, thereby inhibiting vascular and soft tissue calcification." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evide… (Nutrients 2020) · cited 53x in the literature
"The findings indicate that vitamin K does not consistently prevent progression of calcification, atherosclerosis or arterial stiffness. ... While vitamin K supplementation clearly improves the carboxylation of dephosphoylated MGP, its role in mitigating vascular calcification is uncertain, based on current evidence." (abstract, conclusions)
pubmedfull study (doi) - contradicts: Vitamin K supplementation impact in dialysis patients: a systematic review and meta-analys… (Clinical kidney journal 2023) · cited 4x in the literature
"While it did not have a proved benefit in changing calcification scores [-0.14 (-0.37 ± 0.09)], vitamin K proved to be a safe product." (abstract, results, passage verified)
pubmedfull study (doi)
Heart arrhythmia is one of the earliest symptoms of magnesium deficiency.
"because one of the first signs of a magnesium deficiency is the heart arrhythmia issues." (said at 0:39:09)
The claim is overstated. While magnesium deficiency directly impairs myocardial electrical stability and can induce arrhythmias (including atrial fibrillation, flutter, and ventricular arrhythmias), cardiac arrhythmias are generally considered manifestations of more pronounced or severe hypomagnesemia rather than the earliest or initial symptoms. The earliest clinical signs of magnesium deficiency are typically non-specific systemic and neuromuscular symptoms, such as loss of appetite, nausea, fatigue, weakness, muscle cramps, and tremors, whereas arrhythmias and severe cardiac conduction abnormalities typically develop as depletion progresses.
Loose otolith calcium crystals in the inner ear that cause dizziness can be treated with vitamin D and K2.
"these little um calcium uh pieces break off in the inner ear and they float around. They can cause disorientation and dizziness, in which case the remedy would be vitamin D and K2." (said at 0:49:37)
The primary and definitive treatment for loose otolith crystals causing benign paroxysmal positional vertigo (BPPV) is mechanical repositioning (such as the Epley or canalith repositioning maneuvers), not vitamin supplementation. Randomized controlled trials and meta-analyses show that vitamin D supplementation (often combined with calcium) can modestly reduce the rate of BPPV recurrence in patients who are deficient in vitamin D following successful repositioning maneuvers. However, vitamin D is not an acute remedy to dissolve or reposition displaced crystals, and there is no robust clinical trial evidence demonstrating that vitamin K2 treats or prevents BPPV.
Nearly every person has cancer cells living in their body at any given time.
"pretty much everyone if not everyone has cancer cells living in their body." (said at 0:52:30)
The claim that nearly everyone has cancer cells in their body at any given time conflates somatic DNA mutations and cellular damage with established cancer cells, and overgeneralizes findings from occult microtumors in older adults to the entire population. While cellular mutations and clonal expansions occur continuously across the human lifespan, healthy cellular repair mechanisms and immune surveillance typically eliminate damaged cells before they acquire the hallmarks of cancer. Systematic reviews of autopsy studies demonstrate that while incidental occult micro-cancers and precursor lesions (such as latent prostate, thyroid, or in situ breast lesions) are relatively common in older adults (e.g., reaching up to ~59% in men over 79 for occult prostate cancer and ~19.5% for incidental breast neoplasia/precursors), their prevalence is low in younger individuals (e.g., ~5% in men under 30) and far from ubiquitous across the general population at any given time.
Inactive forms of vitamin B6 and folic acid accumulate toxically if not supplied in their active state to individuals with genetic methylation issues.
"The same exact thing with vitamin um B6 and folic acid. So there's certain nutrients that you you need to get them in their active state uh especially if there's a genetic issue." (said at 1:01:50)
While high doses of inactive vitamin B6 (pyridoxine) can cause sensory neuropathy by competitively inhibiting active pyridoxal-5'-phosphate (PLP) and pyridoxal kinase (PDXK), this toxicity is caused by excessive dosage rather than underlying genetic methylation defects. Similarly, high intake of synthetic folic acid can result in circulating unmetabolized folic acid (UMFA), and single nucleotide polymorphisms in the folate pathway (such as MTHFR) affect one-carbon metabolism; however, current evidence does not demonstrate that inactive forms of B6 and folate accumulate toxically specifically as a result of genetic methylation issues.
- partial: The vitamin B6 paradox: Supplementation with high concentrations of pyridoxine leads to de… (Toxicology in vitro : an international journal published in association with BIBRA 2017) · cited 157x in the literature
"The inactive form pyridoxine competitively inhibits the active pyridoxal-5'-phosphate. Consequently, symptoms of vitamin B6 supplementation are similar to those of vitamin B6 deficiency." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: Vitamin B-6-Induced Neuropathy: Exploring the Mechanisms of Pyridoxine Toxicity. (Advances in nutrition (Bethesda, Md.) 2021) · cited 119x in the literature
"High circulating concentrations of PN may lead to a similar condition via the inhibition of PDXK." (abstract, results, passage verified)
pubmedfull study (doi) - context: Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Aff… (Biomolecules 2022) · cited 201x in the literature
"The issue surrounding FA and its association with UMFA (unmetabolized folic acid) syndrome is now a matter of concern, as UMFA is currently found in the umbilical cord of the fetus, and even in infants' blood." (abstract, results, passage verified)
pubmedfull study (doi)
3 Needs context
In one study, 47 out of 100 people using a low-carbohydrate diet reversed diabetes in 3 months.
"In one study, it showed that 47 people out of 100 using low carb can actually reverse diabetes in 3 months." (said at 0:14:40)
The claim likely refers to landmark clinical trial findings such as the DiRECT trial, in which 46% (68 of 149) of adults with type 2 diabetes achieved remission at 12 months. However, that intervention was an intensive low-energy total diet replacement formula (825–853 kcal/day) followed for 3 to 5 months, not a standard low-carbohydrate diet, with the primary remission outcome assessed at 12 months. A systematic review and meta-analysis of randomized clinical trials of low-carbohydrate diets found that low-carbohydrate diets achieved diabetes remission in 57% of participants at 6 months compared to 31% on control diets, though remission rates diminished at 12 months.
- context: Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-labe… (Lancet (London, England) 2018) · cited 2097x in the literature
"The intervention comprised withdrawal of antidiabetic and antihypertensive drugs, total diet replacement (825-853 kcal/day formula diet for 3-5 months), stepped food reintroduction (2-8 weeks), and structured support for long-term weight loss maintenance... Diabetes remission was achieved in 68 (46%) participants in the intervention group and six (4%) participants in the control group (odds ratio 19·7, 95% CI 7·8-49·8; p<0·0001)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: … (BMJ (Clinical research ed.) 2021) · cited 431x in the literature
"At six months, compared with control diets, LCDs achieved higher rates of diabetes remission (defined as HbA 1c <6.5%) (76/133 (57%) v 41/131 (31%); risk difference 0.32, 95% confidence interval 0.17 to 0.47; 8 studies, n=264, I 2 =58%)." (abstract, results, passage verified)
pubmedfull study (doi)
Randomized controlled trials show that omega-3 fatty acids help improve insulin resistance.
"There's actually a randomized control trial on this. I can't tell you the exact one, but did a video on it and um yeah, omega-3 fatty acids can help um insulin resistance." (said at 1:00:13)
Randomized controlled trials (RCTs) and comprehensive meta-analyses show that omega-3 fatty acid supplementation has little to no overall effect on insulin resistance or glycemic control in the general population or in patients with type 2 diabetes. A major BMJ meta-analysis of 83 RCTs found that long-chain omega-3 supplementation had no significant effect on HOMA-IR (mean difference 0.06, 95% CI -0.21 to 0.33) or risk of diabetes. Subsequent meta-analyses in type 2 diabetes patients similarly found no significant impact on insulin resistance (HOMA-IR). However, modest improvements in insulin resistance and fasting insulin have been observed in specific subgroup populations, such as women with polycystic ovary syndrome (PCOS). Therefore, while RCTs exist showing benefits in specific conditions like PCOS, claiming broadly that RCTs show omega-3 fatty acids improve insulin resistance requires qualification, as large-scale evidence in general and diabetic populations shows no meaningful effect.
- contradicts: Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of ty… (BMJ (Clinical research ed.) 2019) · cited 319x in the literature
"Long chain omega-3 had little or no effect on likelihood of diagnosis of diabetes... or measures of glucose metabolism (HbA 1c mean difference -0.02%, 95% confidence interval -0.07% to 0.04%; plasma glucose 0.04, 0.02 to 0.07, mmol/L; fasting insulin 1.02, -4.34 to 6.37, pmol/L; HOMA-IR 0.06, -0.21 to 0.33)." (abstract, results)
pubmedfull study (doi) - contradicts: The effects of omega-3 fatty acids in type 2 diabetes: A systematic review and meta-analys… (Prostaglandins, leukotrienes, and essential fatty acids 2022) · cited 50x in the literature
"There was no significant effect on renal function, fasting blood sugar (FBS), insulin resistance (HOMA-IR), low-density lipoprotein cholesterol (LDL-C), adiponectin and leptin (p > 0.05)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Effects of n-3 polyunsaturated fatty acid on metabolic status in women with polycystic ova… (Journal of ovarian research 2023) · cited 16x in the literature
"Compared with control group, n-3 PUFA treatment decreased waist circumference... fasting plasma glucose... fasting insulin... homeostatic model assessment of insulin resistance (MD = -0.45, 95% CI: -0.80 to -0.11; p = 0.01)... in PCOS patients." (abstract, results)
pubmedfull study (doi)
Probiotics can worsen symptoms in people with ulcers who also have small intestinal bacterial overgrowth (SIBO).
"And then people that have ulcers usually have other issues with the digestion like maybe SIBO and then that probiotic can actually make it worse." (said at 1:05:18)
An observational study led by Rao et al. (PMID: 29915215) observed that probiotic use in individuals with small intestinal bacterial overgrowth (SIBO) and D-lactic acidosis was associated with symptoms such as brain fogginess, abdominal bloating, and gas, and that discontinuing probiotics along with antibiotic treatment led to symptom resolution in 77% of affected patients. Furthermore, the American Gastroenterological Association's clinical practice update (PMID: 37452811) advises that probiotics should not be used to treat abdominal bloating and distention. However, meta-analyses of clinical trials examining probiotics in SIBO (e.g., PMID: 28267052) indicate that probiotics can actually aid in SIBO decontamination and reduce abdominal pain. There is no specific evidence showing that having gastric or duodenal ulcers uniquely alters or worsens this probiotic-SIBO interaction.
- contradicts: Probiotics for Preventing and Treating Small Intestinal Bacterial Overgrowth: A Meta-Analy… (Journal of clinical gastroenterology 2017) · cited 156x in the literature
"The present findings indicated that probiotics supplementation could effectively decontaminate SIBO, decrease H2 concentration, and relieve abdominal pain, but were ineffective in preventing SIBO." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Brain fogginess, gas and bloating: a link between SIBO, probiotics and metabolic acidosis. (Clinical and translational gastroenterology 2018) · cited 164x in the literature
"We describe a syndrome of BF, gas and bloating, possibly related to probiotic use, SIBO, and D-lactic acidosis in a cohort without short bowel. Patients with BF exhibited higher prevalence of SIBO and D-lactic acidosis. Symptoms improved with antibiotics and stopping probiotics." (abstract, conclusions, passage verified)
pubmedfull study (doi) - context: AGA Clinical Practice Update on Evaluation and Management of Belching, Abdominal Bloating,… (Gastroenterology 2023) · cited 68x in the literature
"BEST PRACTICE ADVICE 10: Probiotics should not be used to treat abdominal bloating and distention." (abstract, best practice advice, passage verified)
pubmedfull study (doi)
16 Supported by research
Allithiamine is a natural fat-soluble form of vitamin B1 derived from garlic that crosses the blood-brain barrier.
"The natural B1, allithiamine, actually, believe it or not, is natural, comes from garlic. It's the one I like, is fat soluble... but the natural garlic version, allithiamine, thiamine, apparently does cross the blood-brain barrier and affects the cognitive, the brain function" (said at 0:09:30)
Published literature confirms that allithiamine is a natural, lipid/fat-soluble thiamine (vitamin B1) derivative formed in plants of the genus Allium (such as garlic) when allicin reacts with thiamine upon crushing or cutting the bulb. Unlike standard water-soluble thiamine salts, lipid-soluble thiamine disulfide derivatives easily cross biological membranes, including the blood-brain barrier, significantly raising central nervous system thiamine levels and supporting neurological/cognitive function.
Benfotiamine is a synthetic fat-soluble form of vitamin B1 that lacks substantial data showing it penetrates the brain.
"benfotiamine, which is very good for very specific things, more peripheral, like the nerves in the bottom of the feet or the hands. But sometimes it tends to work also for other type of nerve problems that are maybe autonomic nerves. There's not a lot of data that it penetrates the brain" (said at 0:09:40)
The host's statement that there is not a lot of data showing benfotiamine penetrates the brain is supported by published pharmacological research. Comparative preclinical studies demonstrate that while oral benfotiamine significantly increases thiamine levels in peripheral tissues like blood and liver, it does not significantly elevate thiamine or thiamine diphosphate levels in brain tissue, in contrast to true lipophilic thiamine disulfides such as sulbutiamine. Although some neurodegeneration animal models report modest secondary cerebral effects or localized thiamine derivative changes following prolonged high-dose administration, direct evidence of efficient blood-brain barrier penetration by benfotiamine remains limited.
Scientific data shows that nicotine reduces the risk of Parkinson's disease.
"there is some data to show that nicotine does reduce the risk of Parkinson's, for example." (said at 0:16:11)
Epidemiological observational data indicate an inverse association between nicotine exposure (including smokeless tobacco like snus and cigarette smoking) and the risk of developing Parkinson's disease. For instance, a meta-analysis of prospective cohort studies examining non-smoking men who used Swedish moist smokeless tobacco (snus) found that ever-users of snus had approximately a 60% lower risk of Parkinson's disease compared to never-users (pooled HR 0.41, 95% CI 0.28–0.61), suggesting that nicotine or other non-combustion constituents of tobacco may lower Parkinson's risk. However, evidence for direct neuroprotective efficacy in clinical trials of nicotine in patients already diagnosed with Parkinson's disease has failed to demonstrate motor benefit, and reverse causation (prodromal loss of reward-seeking behavior) remains a potential confounding explanation in epidemiological studies.
A substantial portion of bone tissue is composed of collagen.
"Realize also a good portion of the bone is collagen." (said at 0:07:40)
Bone tissue is a composite material composed of an inorganic mineral phase (primarily hydroxyapatite) and an organic matrix. Collagen, predominantly type I collagen, constitutes approximately 90% of the organic matrix and roughly 20–30% of total dry bone mass, providing the structural scaffold and tensile strength of bone tissue.
In the United States, a blood pressure reading of 120/80 mmHg is classified as stage 1 hypertension, and clinical guideline changes reclassified 31 million people into the hypertension category overnight.
"Actually, 120 over 80 in America is stage one hypertension. Can you believe that? So they keep lowering the numbers, putting 31 million people into a new category of hypertension overnight." (said at 0:22:40)
Under the 2017 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure guideline, blood pressure categories are defined as Normal (<120/<80 mmHg), Elevated (120-129/<80 mmHg), and Stage 1 hypertension (systolic 130-139 mmHg or diastolic 80-89 mmHg). Because category assignment is determined by the higher of the two readings, a diastolic pressure of 80 mmHg places a reading of 120/80 mmHg into Stage 1 hypertension. Analysis of National Health and Nutrition Examination Survey (NHANES) data published alongside the guidelines established that adopting the 2017 ACC/AHA criteria increased the crude prevalence of hypertension among US adults from 31.9% (72.2 million adults under JNC7 criteria) to 45.6% (103.3 million adults), reclassifying approximately 31.1 million additional individuals into the hypertension category.
The liver does not store toxins; its function is detoxification and converting poisons into harmless particles.
"the liver is not an area that is storing toxins. It's not storing toxins. It's a detoxification, and it helps you turn poisons into harmless particles." (said at 0:27:32)
Established physiological literature confirms that the liver's primary role in handling xenobiotics and metabolic byproducts is biotransformation and detoxification rather than storage. Hepatic enzymes (notably Phase I cytochrome P450 enzymes and Phase II conjugation pathways) convert lipophilic toxins and foreign compounds into water-soluble, less toxic metabolites for elimination via bile or urine. While lipophilic persistent pollutants are predominantly stored in adipose tissue and heavy metals in bone, the liver functions as a processing and clearance organ rather than a storage depot.
- supports: Xenobiotic-induced liver injury: Molecular mechanisms and disease progression. (Ecotoxicology and environmental safety 2025) · cited 33x in the literature
"The liver, as the body's principal detoxification organ, is especially vulnerable to these substances, which are commonly encountered through ingestion, inhalation, or dermal exposure." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Xenobiotics Induced Liver Toxicity. (Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki) 2026)
"The liver, as the primary organ responsible for biotransformation, plays a central role in the detoxification and activation of these compounds." (abstract, results, passage verified)
pubmedfull study (doi)
Fasting causes a surge in growth hormone that preserves muscle tissue from breakdown.
"Well, realize when you're fasting, your growth hormone is just spiking. And one of the big purposes of growth hormone is preservation of muscle so you don't lose muscle." (said at 0:39:46)
Human metabolic and endocrinological studies demonstrate that fasting triggers an increase in pulsatile growth hormone (GH) secretion, and that GH plays a key physiological role in protein conservation by suppressing muscle protein breakdown. In controlled crossover experiments in healthy adults undergoing short-term fasting (such as 40 hours), pharmacological suppression of GH substantially increased urea nitrogen excretion and whole-body/muscle protein degradation, while exogenous GH replacement restored protein-sparing and reduced muscle protein breakdown rates.
Research shows slow breathing can significantly reduce blood pressure in a very short period of time.
"because the the research on that is the the slow breathing can drop your blood pressure significantly in a very short period of time." (said at 0:44:12)
Published clinical trials and meta-analyses support the claim that slow breathing exercises can acutely and significantly lower blood pressure within short periods of time (such as during or immediately following a single session lasting 10–15 minutes, as well as over short intervention periods). A 2024 systematic review and meta-analysis of randomized controlled trials demonstrated that breathing exercises significantly reduce systolic blood pressure by an average of 7.06 mm Hg and diastolic blood pressure by 3.43 mm Hg. Acute laboratory trials also confirm that single sessions of slow breathing acutely decrease sympathetic nerve activity, improve baroreflex sensitivity, and lower blood pressure.
- supports: Device-guided slow breathing reduces blood pressure and sympathetic activity in young norm… (Journal of applied physiology (Bethesda, Md. : 1985) 2019) · cited 27x in the literature
"Overall, SLOWB reduced systolic BP by 3.2 ± 0.8 mmHg (main effect, P < 0.01)... SLOWB also reduced muscle sympathetic nerve activity burst incidence by -5.0 ± 1.4 bursts/100 heartbeats (main effect, P < 0.01)." (abstract, results)
pubmedfull study (doi) - supports: Effect of breathing exercises on blood pressure and heart rate: A systematic review and me… (International journal of cardiology. Cardiovascular risk and prevention 2024) · cited 26x in the literature
"Breathing exercises have a modest but significant effect on decreasing systolic blood pressure (-7.06 [-10.20, -3.92], P = <0.01) and diastolic blood pressure (-3.43 [-4.89, -1.97], P = <0.01) mm Hg." (abstract, results, passage verified)
pubmedfull study (doi)
Exhaling slowly stimulates the vagus nerve and activates the parasympathetic nervous system.
"When you breathe out, you stimulate the vagus nerve. This is parasympathetic. That's really what does the magic is the breathing out slowly a little longer than the inhalation." (said at 0:44:24)
The claim is supported by physiological literature on respiratory sinus arrhythmia and autonomic control. During exhalation, vagal nerve outflow to the heart increases (cardiac vagal tone), leading to parasympathetic activation and heart rate deceleration. Experimental studies manipulating breathing ratios demonstrate that prolonging exhalation relative to inhalation increases high-frequency heart rate variability (HF-HRV) and root mean square of successive differences (RMSSD), direct indices of vagal/parasympathetic tone, both at resting rates and during slow-paced breathing.
- supports: Inhalation/Exhalation ratio modulates the effect of slow breathing on heart rate variabili… (Applied psychophysiology and biofeedback 2014) · cited 249x in the literature
"A low i/e ratio was also associated with more power in the high frequency component of heart rate variability, but only for the slow breathing pattern. Our results show that i/e ratio is an important modulator for the autonomic and subjective effects of instructed ventilatory patterns." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Increased exhalation to inhalation ratio during breathing enhances high-frequency heart ra… (Psychophysiology 2021) · cited 62x in the literature
"These findings suggest that longer duration of exhalation relative to inhalation, without altering breathing rate, acutely increased RMSSD and HF-HRV, consistent with enhancement of cardiac vagal tone." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Breathe better, live better: the science of slow breathing and heart rate variability. (Acta neurologica Belgica 2025) · cited 14x in the literature
"RSA increased significantly in studies utilizing tailored breathing patterns, especially those emphasizing longer exhalations." (abstract, results, passage verified)
pubmedfull study (doi)
Sauna exposure increases growth hormone significantly more than cold plunges.
"What increases more growth hormone, cold plunge or sauna? 70% say it's the old cold plunge. Uh, and then 30% say it's sauna. Where where are we on that? HOST: Sauna, but significantly." (said at 0:58:35)
Physiological studies demonstrate that heat exposure, such as sauna bathing, causes a marked acute increase in circulating growth hormone levels, whereas cold exposure (such as cold water immersion or cold stress) does not increase growth hormone and can suppress its secretion. Research comparing thermal stimuli in humans found that central cooling suppresses growth hormone secretion while heating induces a pronounced increase (PMID: 6858704). Studies on cold water swimming show no significant change in growth hormone levels (PMID: 7710600), whereas sauna exposure consistently elevates anterior pituitary growth hormone release (PMID: 3218898).
- supports: How the sauna affects the endocrine system. (Annals of clinical research 1988) · cited 58x in the literature
"The concentrations of the growth hormone and prolactin, in particular, secreted from the anterior pituitary are increased in the circulation." (abstract, results, passage verified)
pubmed - supports: The effect of heating and central cooling on serum TSH, GH, and norepinephrine in resting … (Acta physiologica Scandinavica 1983) · cited 33x in the literature
"Cooling induced a virtually complete suppression of GH-secretion whereas heating had the opposite effect: pronounced increase, also without previous cooling." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Acute and chronic effects of winter swimming on LH, FSH, prolactin, growth hormone, TSH, c… (Arctic medical research 1995) · cited 41x in the literature
"There were mild decreases in prolactin serum levels after cold stress, whereas FSH, LH and growth hormone remained unaltered." (abstract, results, passage verified)
pubmed
Whole-body vibration plates are effective for managing and improving osteoporosis.
"And then also lastly, uh the vibration plates. I don't know if you're doing that, but that tends to be really good for osteoporosis as well." (said at 0:37:45)
Multiple systematic reviews and meta-analyses of randomized controlled trials demonstrate that whole-body vibration (WBV) therapy leads to statistically significant improvements in bone mineral density (BMD), particularly at the lumbar spine and femoral neck/trochanter, in postmenopausal women with osteoporosis or osteopenia. Although effect sizes are modest and depend on vibration parameters (such as frequency, magnitude, and cumulative dose), the clinical literature supports WBV as an effective non-pharmacological adjunct for managing bone loss.
- supports: Effectiveness of whole-body vibration on bone mineral density in postmenopausal women: a s… (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2023) · cited 43x in the literature
"The present study observed significant effects of whole-body vibration (WBV) on bone mineral density (BMD) in postmenopausal women, with high-quality evidence for high-frequency, low-magnitude, and high-cumulative-dose use... At this time, considering the high quality of evidence, it is possible to recommend WBV using high frequency (≈ 30 Hz), low magnitude (≈ 0.3 g), and high cumulative dose (≈ 7000 min) to improve lumbar spine aBMD in postmenopausal women." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Therapeutic effects of whole-body vibration on postmenopausal women with osteoporosis: a s… (Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2024) · cited 4x in the literature
"The meta-analysis results showed that WBV can significantly increase lumbar spine BMD (WMD=0.018; 95%CI: 0.004 to 0.032; P=0.011), femoral neck BMD (WMD=0.005, 95%CI: 0.001 to 0.011, P=0.0493), and reduce pain degree (WMD=-0.786; 95%CI: -1.300 to -0.272; P=0.0027) in PMOP... To conclude, WBV showed the potential to provide positive benefits in improving BMD and relieving pain of PMOP." (abstract, results and conclusions, passage verified)
pubmedfull study (doi)
Antibiotics lead to yeast overgrowth because yeast are not killed by antibiotics while the bacteria that suppress yeast are eliminated.
"because yeast don't die from antibiotics. So, the antibiotics create a yeast overgrowth because you you got rid of the the police officers, the bacteria." (said at 0:54:55)
The speaker's explanation reflects the established mechanism of antibiotic-induced fungal dysbiosis. Antibacterial agents specifically target bacteria rather than eukaryotic yeasts like Candida albicans. In healthy mucosal niches (such as the gastrointestinal and vaginal tracts), commensal bacterial microbiota provide colonization resistance by competing for nutrients and space, producing inhibitory metabolites (such as short-chain fatty acids and bacteriocins), and preventing fungal overgrowth and virulence. When antibacterial treatments deplete these protective bacterial populations, the loss of competitive inhibition permits unaffected yeast populations to proliferate.
- supports: In vitro studies on colonization resistance of the human gut microbiota to Candida albican… (Current issues in intestinal microbiology 2003) · cited 72x in the literature
"During steady state conditions, overgrowth of C. albicans was prevented by commensal bacteria indigenous to the system. However antibiotics, such as tetracycline have the ability to disrupt the bacterial populations within the gut. Thus, colonization resistance can be compromised and overgrowth of undesirable microorganisms like C. albicans can then occur. In this study, growth of C. albicans was not observed in the presence of an established faecal microbiota. However, following the addition of tetracycline to the growth medium, significant growth of C. albicans occurred." (abstract, passage verified)
pubmed - supports: Keeping Candida commensal: how lactobacilli antagonize pathogenicity of Candida albicans i… (Disease models & mechanisms 2019) · cited 86x in the literature
"In this reservoir, the fungus exists as a harmless commensal. However, antibiotic treatment can disturb the bacterial microbiota, facilitating fungal overgrowth and favoring pathogenicity." (abstract, passage verified)
pubmedfull study (doi)
Bile backing up into the skin causes itching and tissue inflammation.
"bile um can back up into even our skin and create itching and it's like uh it's very very irritating to our tissues uh and create inflammation." (said at 1:03:17)
During cholestasis (impaired bile formation or flow), bile acids and other bile components back up into the systemic circulation and deposit in peripheral tissues, including the skin. In the skin and sensory nervous system, bile acids act as pruritogens by activating receptors such as TGR5 (GPBAR1) and downstream ion channels like TRPA1 on sensory nerve fibers, stimulating the release of pruritogenic neuropeptides that cause severe itching. In addition, bile acids possess detergent properties that cause irritation and inflammatory signaling when concentrated in tissues.
- supports: The TGR5 receptor mediates bile acid-induced itch and analgesia. (The Journal of clinical investigation 2013) · cited 380x in the literature
"We report that bile acids, which are elevated in the circulation and tissues during cholestasis, cause itch and analgesia by activating the GPCR TGR5... Thus, bile acids activate TGR5 on sensory nerves, stimulating the release of neuropeptides in the spinal cord that transmit itch and analgesia." (abstract, results)
pubmedfull study (doi) - supports: The bile acid receptor TGR5 activates the TRPA1 channel to induce itch in mice. (Gastroenterology 2014) · cited 224x in the literature
"Patients with cholestatic disease have increased systemic concentrations of bile acids (BAs) and profound pruritus... BAs induce pruritus in mice by co-activation of TGR5 and TRPA1." (abstract, results/conclusions)
pubmedfull study (doi) - supports: Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments. (Biomolecules 2024) · cited 7x in the literature
"Cholestasis is a clinical and laboratory syndrome indicating impaired bile production or excretion. One of the hallmark symptoms of cholestasis is pruritus. Itch can be severe and debilitating for patients, impacting their quality of life similarly to pain, and, in some cases, it can be refractory." (abstract, passage verified)
pubmedfull study (doi)
Bile in the small intestine kills bacteria to prevent bacterial overgrowth.
"we do need it also in our small intestine to kill off even the bad bacteria that so we don't get this overgrowth of bacteria in our small intestine." (said at 1:03:30)
Bile acids secreted into the small intestine possess antibacterial and antimicrobial properties that help regulate the gut microbiome and prevent small intestinal bacterial overgrowth (SIBO). Impairment in bile acid secretion or metabolism is a recognized mechanism contributing to bacterial overgrowth and dysbiosis in the small bowel, and administration of bile acids (such as ursodeoxycholic acid) has been demonstrated to reduce bacterial overgrowth markers.
Zinc carnosine specifically helps heal stomach ulcers.
"I think uh you need zinc carnosine specifically that will help heal the ulcer." (said at 1:04:52)
Zinc L-carnosine (also known as polaprezinc) is a chelated compound approved and widely utilized as a mucosal protective agent for treating gastric ulcers. Multicenter randomized controlled trials and clinical reviews demonstrate that oral zinc carnosine promotes gastric mucosal healing, demonstrating endoscopic ulcer healing rates comparable to other standard mucosal protective agents (such as rebamipide) with significant symptom improvement.
- supports: A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, … (Nutrients 2020) · cited 56x in the literature
"The research supports its use for gastric ulcers (approved in Japan) and conditions of the upper GI and suggests other applications, particularly for oral mucositis." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal d… (Clinics and research in hepatology and gastroenterology 2022) · cited 22x in the literature
"It has been shown to promote repair of mucosal injury in human studies and has been widely used for the treatment of peptic ulcers, chemoradiotherapy-induced oral mucositis and esophagitis." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Efficacy and safety of polaprezinc in the treatment of gastric ulcer: A multicenter, rando… (Medical engineering & physics 2022) · cited 5x in the literature
"For the primary efficacy endpoint, the effective rates confirmed by gastroscopy, after treatment for the test and control groups were 81.48% and 74.31% (P = 0.1557), respectively... These findings suggest that the efficacy and safety of polaprezinc were similar to those of rebamipide in the treatment of GU." (abstract, results)
pubmedfull study (doi)
Cabbage juice contains vitamin U, also known as S-methylmethionine.
"Uh there's also vitamin U in cabbage juice. Um it's called S-methylmethionine." (said at 1:05:00)
Cabbage and cabbage juice are well-established dietary sources of S-methylmethionine, a methionine derivative historically termed "vitamin U" (the "U" originally standing for anti-ulcer factor).
8 No source found (not proven false)
Topically applying DMSO to the skin, such as on the foot, penetrates rapidly enough to produce a taste sensation in the mouth within seconds.
"what's wild is you could actually put some on your foot and you literally within seconds you're tasting it. I don't know how that works, but it's a super solvent that will go deep and penetrate into the skin" (said at 0:08:25)
No published record matching the specific claim that topically applying DMSO to the skin (such as on the foot) produces a taste sensation in the mouth within seconds was located; this does not prove the claim false.
Randomized controlled trials show that garlic, hibiscus tea, and nasal breathing can lower blood pressure.
"there's many, many other things that you can do on randomized control trials that can bring down blood pressure: garlic, hibiscus tea, breathing through your nose at night" (said at 0:21:30)
The host's statement bundles three distinct interventions claimed to lower blood pressure in randomized controlled trials (RCTs):
1. Garlic: Supported. Meta-analyses of RCTs demonstrate that garlic supplementation (such as aged garlic) modestly reduces systolic blood pressure (e.g., weighted mean difference of -2.49 mmHg).
2. Hibiscus tea (Hibiscus sabdariffa): Supported. Meta-analyses of RCTs confirm that hibiscus tea significantly lowers both systolic blood pressure (by approximately 4.7 to 7.6 mmHg) and diastolic blood pressure (by 3.5 to 4.1 mmHg).
3. Breathing through your nose at night: Unverified. No published randomized controlled trial evaluating nocturnal nasal breathing or mouth taping for blood pressure reduction was located; this does not prove the claim false.
Because the statement bundles these assertions together and no RCT evidence was located for nocturnal nasal breathing, the overall claim is rated unverified.
- supports: Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: a systematic review … (Journal of hypertension 2015) · cited 130x in the literature
"Fixed-effect meta-regression indicated a significant effect of H. sabdariffa supplementation in lowering both SBP (weighed mean difference -7.58 mmHg, 95% confidence interval -9.69 to -5.46, P < 0.00001) and DBP (weighed mean difference -3.53 mmHg, 95% confidence interval -5.16 to -1.89, P < 0.0001)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk … (Phytotherapy research : PTR 2020) · cited 42x in the literature
"Pooled effect size demonstrated that sour tea consumption significantly reduces fasting plasma glucose (-3.67 mg/dl, 95% CI [-7.07, -0.27]; I 2 = 37%), systolic blood pressure (-4.71 mmHg, 95% CI [-7.87, -1.55]; I 2 = 53%), and diastolic blood pressure (-4.08 mmHg, 95% CI [-6.48, -1.67]; I 2 = 14%)." (abstract, results)
pubmedfull study (doi) - supports: The Effect of Aged Garlic Supplementation on Blood Pressure and Lipid Profile: A Dose-Resp… (Phytotherapy research : PTR 2025) · cited 2x in the literature
"AG consumption significantly reduced SBP (WMD: -2.49 mmHg; 95% CI: -4.02 to -0.95; I 2 = 29.76%)" (abstract, results, passage verified)
pubmedfull study (doi)
Consuming a sugary or starchy snack three hours before bed reduces growth hormone secretion by 78%.
"consuming a sugary starch snack three hours before bed uh can shut down your growth hormone by 78%. 98% of respondents say it's true. And 2% say, "Nope, you're just fine." HOST: It's it's true." (said at 0:31:18)
No published record matching the claim that consuming a sugary or starchy snack three hours before bed reduces growth hormone secretion by 78% was located; this does not prove the claim false.
The body experiences a surge of growth hormone that lasts for 90 minutes right upon going to sleep.
"Through the entire day and night, you have this massive spike, 90 minutes of this surge of growth hormone that happens right when you go to bed for 90 minutes." (said at 0:31:50)
No published record matching the claim that the body experiences a 90-minute surge of growth hormone right upon going to sleep was located; this does not prove the claim false.
Adding dietary protein interrupts the process of autophagy during fasting.
"As soon as you start adding protein now we don't get the results of autophagy. Okay? You get other benefits, weight loss, but not autophagy." (said at 0:40:04)
No published record matching the claim that adding dietary protein interrupts the process of autophagy during fasting was located; this does not prove the claim false.
Intermittent and prolonged fasting can resolve eye floaters by clearing out excess protein floating in the eyeball.
"Yes, do more intermittent fasting and prolonged fasting, which will clean up that extra protein that's floating around your eyeball." (said at 0:40:03)
No published record matching the claim that intermittent or prolonged fasting can resolve eye floaters by clearing out excess protein in the eye was located; this does not prove the claim false. Vitreous floaters typically arise from age-related liquefaction of the vitreous humor (syneresis), posterior vitreous detachment, and the aggregation of structural collagen fibrils, for which standard medical management is limited to observation, pars plana vitrectomy, or Nd:YAG laser vitreolysis.
Cold plunging stimulates neurogenesis and the growth of new brain cells.
"It basically it creates some pretty wild stuff in your brain as far as uh growing new brain cells." (said at 0:58:50)
No published record matching the claim that cold plunging stimulates neurogenesis or the growth of new brain cells in humans was located; this does not prove the claim false.
Preclinical laboratory research in animal models and cell cultures has examined hypothermia, cold shock proteins (such as RBM3), and cold stress in rodents. For instance, studies have shown that mild hypothermia (35°C) promotes neuronal differentiation of cultured human neural stem cells (PMID: 38523796) and that RBM3 plays a role in neural stem cell differentiation and neuroprotection after brain injury or cold stress in rodents (PMID: 31484925, PMID: 30037926). Additionally, a mouse study found that cold water immersion altered hippocampal brain-derived neurotrophic factor (BDNF) and signaling pathways (PMID: 40752721). However, no clinical studies demonstrate that cold plunging or cold water immersion in humans stimulates adult neurogenesis or grows new brain cells.
- context: RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway aft… (Nature communications 2019) · cited 98x in the literature
"Here we show how RBM3 stimulates neuronal differentiation and inhibits HI-induced apoptosis in the two areas of persistent adult neurogenesis, the subventricular zone (SVZ) and the subgranular zone (SGZ), while promoting neural stem/progenitor cell (NSPC) proliferation after HI injury only in the SGZ." (abstract, results, passage verified)
pubmedfull study (doi) - context: Mild hypothermia promotes neuronal differentiation of human neural stem cells via RBM3-SOX… (iScience 2024) · cited 10x in the literature
"In conclusion, our study highlights that mild hypothermia at 35°C enhances hNSCs-induced neurogenesis through the novel RBM3-SOX11 signaling pathway, and provides a potential treatment strategy in brain disorders." (abstract, conclusions, passage verified)
pubmedfull study (doi) - context: Impact of cold exposure duration and intensity on hippocampal tyrosine hydroxylase, brain-… (Experimental neurology 2025) · cited 3x in the literature
"These findings demonstrate the complex interplay between cold stress, hippocampal signalling, and neuroprotective mechanisms, with implications for understanding the brain's response to environmental stressors." (abstract, conclusions, passage verified)
pubmedfull study (doi)
TUDCA keeps bile ducts open to prevent bile sludge from backing up into the pancreas and causing pancreatic necrosis.
"TUDCA is a good supplement for pancreatic health. Um, and also TUDCA keeps the the little bile ducts that come from your liver that join the pancreatic duct right before it goes into the small intestine. And sometimes there could be some sludge there. That's why TUDCA comes in there that then would back up um bile into the pancreas itself creating necrosis breakdown." (said at 1:02:44)
No published record matching the claim that TUDCA keeps bile ducts open to prevent bile sludge from backing up into the pancreas and causing pancreatic necrosis was located; this does not prove the claim false. While tauroursodeoxycholic acid (TUDCA) and related hydrophilic bile acids like ursodeoxycholic acid (UDCA) alter bile acid composition and possess choleretic and cytoprotective properties in preclinical and cholestatic settings, there is no clinical or trial evidence demonstrating that TUDCA supplementation prevents biliary sludge reflux into the main pancreatic duct or prevents acute necrotizing pancreatitis.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.